The Truth About HRT: What Ontario Women Need to Know

Every week, women sit across from me and say some version of the same thing.

"I want help. But I am scared of hormone therapy."

And every week, I ask the same follow-up question: where did that fear come from? Almost always, the answer traces back to the same place. A study published in 2002 that made international headlines, sent prescriptions plummeting, and left a generation of women suffering through perimenopause and menopause without adequate support.

The problem is that study has since been significantly re-evaluated. The conclusions that drove the fear were misapplied and misreported. And in the years since, the evidence in support of hormone therapy for the right women has only grown stronger.

I am Jessica Caceres, a Nurse Practitioner and the founder of Bonita Medical Aesthetics & Wellness in St. Jacobs, Ontario. I am a member of both the Canadian Menopause Society and The Menopause Society. Hormone therapy is one of the most evidence-supported treatments I offer, and I want to address the myths that are keeping women from accessing it.

The Study That Changed Everything (and Why It Was Misread)

The 2002 Women's Health Initiative study was misapplied to younger, perimenopausal women. Its findings have since been significantly reinterpreted by leading menopause researchers worldwide.

In 2002, the Women's Health Initiative (WHI) published results suggesting that hormone therapy increased the risk of breast cancer, heart disease, and stroke. The headlines were alarming. Prescriptions dropped overnight. Doctors who had been supporting their patients through menopause stopped recommending it.

Here is what the reporting missed. The average age of participants in that study was 63. Many had been postmenopausal for over a decade. A significant portion had pre-existing cardiovascular risk factors. The type of progestogen used in the study, medroxyprogesterone acetate, is not the same as the bioidentical progesterone used in modern hormone therapy protocols.

In other words, the results of a study conducted in older women with specific risk profiles were applied broadly to all women considering hormone therapy at any age. That is not how evidence is supposed to work.

The Canadian Menopause Society, The Menopause Society, and menopause specialists around the world have since clarified: for healthy women under 60 or within 10 years of menopause, the benefits of hormone therapy for symptom relief, bone protection, and cardiovascular health generally outweigh the risks. The earlier guidance that caused so much fear does not apply to the majority of women seeking hormone therapy today.

The Myths, Addressed

Myth 1: Hormone therapy causes breast cancer

The absolute risk increase associated with combination HRT and breast cancer is small, equivalent to the risk associated with drinking one to two glasses of alcohol per day or being overweight.

This is the fear I hear most often, and it deserves a direct answer. There is a small increased risk of breast cancer associated with combined estrogen-progestogen therapy, but the magnitude of that risk is frequently overstated. It is comparable to other lifestyle factors that women accept without significant concern. It is also worth noting that estrogen-only therapy (for women who have had a hysterectomy) has not been shown to increase breast cancer risk and may even reduce it.

The decision about hormone therapy is always individual. We review your personal and family history together, your risk factors, and your symptom burden, and we make the decision that makes sense for your specific picture. That is the role of a clinician, not a 20-year-old study headline.

Myth 2: Hormone therapy causes heart attacks

Current evidence shows that hormone therapy started within 10 years of menopause may actually protect cardiovascular health, not harm it. This is known as the timing hypothesis.

The WHI study found increased cardiovascular risk, but again, in older women who were significantly past menopause. More recent research, including the Kronos Early Estrogen Prevention Study (KEEPS), has shown that when hormone therapy is initiated early in the perimenopausal transition, it may have a cardioprotective effect. This is the timing hypothesis: starting hormone therapy during the window of perimenopausal transition appears to be very different from starting it years after the fact.

For women who are symptomatic and within 10 years of their last period, the cardiovascular conversation looks very different than it did in 2002.

Myth 3: Natural menopause is always safer than hormone therapy

Untreated menopause carries its own risks, including bone loss, cardiovascular changes, and cognitive effects. There is no risk-free option, only a risk-benefit conversation.

This framing assumes that doing nothing is a neutral choice. It is not. The hormonal changes of menopause have real consequences for bone density, cardiovascular health, cognitive function, and quality of life. Untreated hot flashes and sleep disruption have downstream effects on mood, relationships, and physical health. Vaginal atrophy, if left unaddressed, worsens over time.

The question is never 'hormones versus no hormones.' It is 'what does the risk-benefit calculation look like for this specific person at this specific point in her transition?' That is a clinical conversation, not a blanket policy.

Myth 4: Bioidentical hormones are completely different and unregulated

Regulated bioidentical hormones are Health Canada approved and clinically validated. They are not the same as compounded hormone preparations sold without oversight.

There is significant confusion between regulated bioidentical hormones (which are approved by Health Canada and have an established evidence base) and compounded bioidentical hormones (which are prepared by compounding pharmacies, are not subject to the same regulatory oversight, and have a more limited evidence base). Both are sometimes called 'bioidentical,' but they are not equivalent.

At Bonita, when I prescribe hormone therapy, I prescribe regulated products with an established evidence base. I can discuss the differences clearly and help you understand exactly what you are taking and why.

Myth 5: Once you start hormone therapy, you can never stop

Hormone therapy can be tapered and discontinued. There is no evidence that stopping HRT causes harm beyond the return of the symptoms it was treating.

This concern comes up often, and it reflects a misunderstanding of how hormone therapy works. It is not a permanent commitment. Many women use it for a defined period during the perimenopausal transition and then taper off gradually. Others choose to continue longer term for bone protection and quality of life. The decision is yours to make with your clinician, and it can be revisited at any time.

Who Is a Good Candidate for Hormone Therapy?

Most healthy women under 60, or within 10 years of menopause, who are experiencing significant symptoms are appropriate candidates for hormone therapy.

The women I see who benefit most from hormone therapy are experiencing one or more of the following: hot flashes or night sweats that are disrupting sleep and daily life, mood changes, anxiety or brain fog that are affecting their functioning, vaginal dryness or discomfort during intimacy, significant sleep disruption, or concerns about bone density.

There are contraindications, and we review them carefully. A history of certain types of breast cancer, unexplained vaginal bleeding, active liver disease, and a history of blood clots are among the factors that require careful consideration or may preclude hormone therapy altogether. That is exactly why an individual assessment matters.

If you are wondering whether hormone therapy might be right for you, the Women's Hormone Quiz on the Bonita website is a good starting point. It takes about five minutes and gives you a clearer picture of your symptom profile, which we can then discuss in a consultation.

What Hormone Therapy Assessment Looks Like at Bonita

When you come to Bonita for a hormone therapy consultation, you will have completed a comprehensive health questionnaire before your appointment and had your lab work done in advance. Your appointment is a review and planning session: we go through your labs, your symptoms, and your health history together, and then we build a plan.

That plan is personalized. It reflects your symptom burden, your risk profile, your goals, and your preferences. It is not a one-size-fits-all protocol because perimenopause is not a one-size-fits-all experience.

Follow-up is built in. Hormone therapy is an ongoing clinical relationship, not a prescription and a goodbye.

No referral is needed. You can book your hormone therapy consultation directly through our website or by calling or texting the clinic at 519-404-3444.

You have been through enough. You deserve a clinician who takes your symptoms seriously, understands the current evidence, and builds a plan that actually addresses the root cause. That is what we do at Bonita.